| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.064 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.8 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |